Nuclera, a biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, has appointed William J Kullback as a non-executive director.
TechnologyLexica: Michèle Wheeler

London-based healthcare and life science consultancy Lexica has appointed Michèle Wheeler as director of international health and life sciences.
Wheeler has more than 35 years’ experience of health and social care services globally. She is an experienced board-level director with a clinical background as a nurse, having worked across acute, primary care, and mental health settings, as well as for the Department of Health and Social Care.
In the private sector, Wheeler has developed and delivered more than 100 projects valued between £12 million and £5 billion across Procure 21-23, PFI, NHS LIFT and other traditional contract forms.
Lexica’s managing director Tina Nolan said. “Michèle is a true industry leader whose global expertise will be invaluable as we expand our international footprint. Her proven track record of transforming healthcare services and leading complex programmes will help elevate our ability to deliver transformative solutions for clients worldwide. Put simply, Michèle is a real feather in our cap.”
Wheeler commented: “Lexica is known for its expertise in healthcare strategy and planning, and more recently in life sciences, especially in the UK, and I look forward to leveraging my network and experience to scale Lexica’s future growth in these areas.”
Latest Executive Moves
Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Jonathan Kempster as an independent non-executive director.
TechnologyStax has appointed Adam Thorpe as a managing director in its London office to lead the firm’s EMEA healthcare vertical.